BLB&B Advisors’s Clorox CLX Stock Holding History

BLB&B Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,197	Closed	-$231K	–	258
2021 Q1	$231K	Buy	1,197 +2	+0.2%	+$385	0.02%	233
2020 Q4	$241K	Buy	+1,195	New	+$247K	0.02%	242

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BLB&B Advisors's CLX Position: Q2 2021 in Review

BLB&B Advisors sold out of Clorox (CLX) in Q2 2021, closing a stake of 1,197 shares — an estimated $231K sold.

BLB&B Advisors first reported a position in CLX in Q4 2020 and held it in 2 quarters. The position peaked at $241K in Q4 2020. 1,168 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

BLB&B Advisors reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
BLB&B Advisors sold 1,197 Clorox shares in Q2 2021, an estimated $231K.
BLB&B Advisors first reported a position in Clorox in Q4 2020 and held it in 2 quarters.
BLB&B Advisors's Clorox position peaked at $241K in Q4 2020.
1,168 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on BLB&B Advisors's 13F filing for Q2 2021, filed 20 Jul 2021.